| 2024 |
Li, M., Bennett, M. K., Toubia, J., Pope, V. S., Tea, M. N., Tamang, S., . . . Pitson, S. M. (2024). An orthotopic syngeneic mouse model of bortezomib-resistant multiple myeloma. British Journal of Haematology, 204(2), 566-570.
DOI Scopus1 WoS1 Europe PMC1 |
| 2022 |
Anshabo, A. T., Bantie, L., Diab, S., Lenjisa, J., Kebede, A., Long, Y., . . . Wang, S. (2022). An Orally Bioavailable and Highly Efficacious Inhibitor of CDK9/FLT3 for the Treatment of Acute Myeloid Leukemia. Cancers, 14(5), 1113.
DOI Scopus13 WoS11 Europe PMC10 |
| 2022 |
Lewis, A. C., Pope, V. S., Tea, M. N., Li, M., Nwosu, G. O., Nguyen, T. M., . . . Pitson, S. M. (2022). Ceramide-induced integrated stress response overcomes Bcl-2 inhibitor resistance in acute myeloid leukemia.. Blood, 139(26), 3737-3751.
DOI Scopus42 WoS37 Europe PMC40 |
| 2021 |
Yu, M., Teo, T., Yang, Y., Li, M., Long, Y., Philip, S., . . . Wang, S. (2021). Potent and orally bioavailable CDK8 inhibitors: design, synthesis, structure-activity relationship analysis and biological evaluation. European Journal of Medicinal Chemistry, 214, 1-22.
DOI Scopus15 WoS14 Europe PMC15 |
| 2021 |
Bennett, M. K., Li, M., Tea, M. N., Pitman, M. R., Toubia, J., Wang, P. P. -S., . . . Pitson, S. M. (2021). Resensitising proteasome inhibitor-resistant myeloma with sphingosine kinase 2 inhibition.. Neoplasia, 24(1), 1-11.
DOI Scopus16 WoS16 Europe PMC14 |
| 2021 |
Yu, M., Long, Y., Yang, Y., Li, M., Teo, T., Noll, B., . . . Wang, S. (2021). Discovery of a potent, highly selective, and orally bioavailable inhibitor of CDK8 through a structure-based optimisation. European Journal of Medicinal Chemistry, 218(113391), 23 pages.
DOI Scopus9 WoS8 Europe PMC9 |
| 2019 |
Khair, N. Z., Lenjisa, J. L., Tadesse, S., Kumarasiri, M., Basnet, S. K. C., Mekonnen, L. B., . . . Wang, S. (2019). Discovery of CDK5 inhibitors through structure-guided approach. ACS, 10(5), 786-791.
DOI Scopus23 WoS21 Europe PMC19 |
| 2019 |
Abdelaziz, A. M., Basnet, S. K. C., Islam, S., Li, M., Tadesse, S., Albrecht, H., . . . Wang, S. (2019). Synthesis and evaluation of 2'H-spiro[cyclohexane-1,3'-imidazo[1,5-a]pyridine]-1',5'-dione derivatives as Mnk inhibitors. Bioorganic & medicinal chemistry letters, 29(18), 2650-2654.
DOI Scopus10 WoS10 Europe PMC7 |
| 2012 |
Chen, L., Liu, W. Q., Lei, J. H., Guan, F., Li, M., Song, W. J., . . . Wang, T. (2012). Chronic schistosoma japonicum infection reduces immune response to vaccine against hepatitis B in mice. PLoS one, 7(12, article no. e51512), 1-7.
DOI Scopus33 Europe PMC32 |
| 2011 |
Li, J., Cao, J., Li, M., Yu, Y., Yang, Y., Xiao, X., . . . Chen, H. (2011). Collagen triple helix repeat containing-1 inhibits transforming growth factor-β1-induced collagen type I expression in keloid. British journal of dermatology, 164(5), 1030-1036.
DOI |
| 2011 |
Yang, Y. F., Sun, Q., Su, B. T., Lin, L., Li, M. J., Chen, L., . . . Li, Y. L. (2011). [Ageing down-modulates the immune responses to Schistosoma japonicum infection in mice].. Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi Chinese Journal of Parasitology Parasitic Diseases, 29(2), 101-104. |
| 2011 |
Li, M. J., Lei, J. H., Wang, T., Lu, S. J., Guan, F., Liu, W. Q., & Li, Y. L. (2011). Cimetidine enhances the protective effect of GST DNA vaccine against Schistosoma japonicum. Experimental parasitology, 128(4), 427-432.
DOI Scopus29 Europe PMC27 |
| 2009 |
Lei, J. H., Liu, W. Q., Sun, C. S., Tang, C. L., Li, M. J., Chen, Y. L., & Li, Y. L. (2009). Detection of circulating antigen in serum of mice infected with Schistosoma japonicum by immunomagnetic bead ELISA based on IgY. Acta tropica, 111(1), 39-43.
DOI Scopus21 Europe PMC21 |
| 2002 |
Fan, H., Huang, M., Wang, Q., & Li, M. J. (2002). Effect of MNNG on ornithine decarboxylase activity in cells from adult Schistosoma japonicum. Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi Chinese Journal of Parasitology Parasitic Diseases, 20(1), 35-36.
Scopus1 Europe PMC1 |
